InsiderTrades

Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP

Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001209191-23-054323 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-11-03 2023-11-01 IART De Witte Jan Pres, CEO, Dir F - Tax $36.85 -4,262 18.4K -19% -$157.1K
D 2023-11-03 2023-11-01 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 +9,814 22.6K +77% $0
D 2023-11-03 2023-11-01 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 -9,814 90.0K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-01 F D 4,262 $36.85 18,350 D — —
2 Common Common Stock 2023-11-01 M A 9,814 $0.00 22,612 D — — (F1) On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The first installment vested on 11/1/2023.
3 Derivative Restricted Stock Units 2023-11-01 M D 9,814 $0.00 90,014 D $0.00 · — to — 9,814 Common Stock (F1) On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The first installment vested on 11/1/2023.